December 14, 2020
Authorized generic (AG) versions of major medicines hit the market on December 11 upon their NHI price listing, including one for Viatris Pharmaceuticals Japan’s flagship pain treatment Lyrica (pregabalin). The Lyrica AG will come in three OD tablet forms, 25...read more